跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
骨折後免疫失調之機轉研究及statin作為其預防及治療的角色:從基礎到臨床(1/2)
Lin, Jui An
(PI)
麻醉學科
研究計畫
:
A - 政府部門
›
b - 國家科學及技術委員會
概覽
指紋
指紋
探索此專案觸及的研究主題。這些標籤是根據基礎獎勵/補助款而產生。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Adaptive Immunity
9%
Albumin
9%
Antagomir
9%
Anti-Inflammatory Drug
9%
Blood Vessel Permeability
9%
Cell Damage
18%
Cytotechnology
9%
Diseases
9%
down Regulation
18%
Dying
9%
Endotoxin
18%
Extravasation
9%
Genetic Transfection
9%
Glycoprotein Gp 96
27%
Granulocyte
9%
Hematoma
9%
Hip Fracture
9%
Human Genome
9%
Immune Disorder
100%
Immunocompetent Cell
9%
Immunosuppressive Drug
9%
Immunosuppressive Treatment
36%
Innate Immunity
9%
Ischemic Heart Disease
9%
Luciferase
9%
Lung
18%
Macrophage
9%
Messenger RNA
18%
microRNA
54%
microRNA 146a
36%
Mononuclear Cell
9%
Myeloperoxidase
9%
Orthopedic Trauma
9%
Orthopedics
9%
Posttranscriptional Regulation
9%
Promoter Region
9%
Receptor
9%
Receptor Expression
9%
Receptor Family
9%
RNA Binding Protein
18%
Sepsis
36%
Serositis
9%
Statin
100%
T Cell
9%
Toll Like Receptor
18%
Toll Like Receptor 4
100%
Untranslated Region
36%
Pharmacology, Toxicology and Pharmaceutical Science
Albumin
9%
Anti-Inflammatory Drug
9%
Diseases
9%
Dying
9%
Endotoxin
18%
Extravasation
9%
Glycoprotein Gp 96
27%
Hematoma
9%
Hip Fracture
9%
Homo sapiens
9%
Immunosuppressive Agent
9%
Inflammation
36%
Ischemic Heart Disease
9%
Luciferase
9%
Messenger RNA
18%
microRNA
54%
microRNA 146a
36%
Mouse Mutant
9%
Myeloperoxidase
9%
Receptor
9%
RNA Binding Protein
18%
Sepsis
36%
Statin (Protein)
100%
Syndrome
9%
Toll Like Receptor
18%
Toll Like Receptor 4
100%
Immunology and Microbiology
Adaptive Immune System
9%
Albumin
9%
Blood Vessel Permeability
9%
Cell Damage
18%
Disease Burden
9%
down Regulation
18%
Dying
9%
Genetic Transfection
9%
Granulocyte
9%
Hip
9%
Homo sapiens
9%
Immune System Disorders
100%
Immunocompetent Cell
9%
Immunosuppression
36%
Immunosuppressive Drug
9%
Inflammation Response
9%
Innate Immune System
9%
Macrophage
9%
Mononuclear Cell
9%
Mouse Mutant
9%
Myeloperoxidase
9%
Promoter Region
9%
Protein RNA Binding
18%
T Cell
9%
TLR4
100%
Toll-Like Receptor
18%
Untranslated Region
36%